Written by Support on 19 June 2017. Posted in Press Releases and Ad-hoc Announcements.

AH: WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates

• PDF File: images/files//2022/20170619_ah_hdp_takeda_adc-collaboration_engl_final.pdf
• Datum: Monday, 19 June 2017 13:07

2017

• Created on 04 November 2021.
• Last updated on 04 November 2021.
• Hits: 1559